Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications

被引:20
|
作者
Elias, Alan N. [1 ]
Hofflich, Heather [1 ]
机构
[1] Univ Calif Irvine, Irvine Med Ctr, Orange, CA 92868 USA
来源
AMERICAN JOURNAL OF MEDICINE | 2008年 / 121卷 / 02期
关键词
atypical antipsychotic agents; carbohydrate intolerance; diabetes; schizophrenia;
D O I
10.1016/j.amjmed.2007.08.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of carbohydrate intolerance and overt diabetes is increased in patients with schizophrenia treated with the newer atypical antipsychotic agents. The precise mechanism for these abnormalities remains obscure. This review examines the potential interaction between atypical antipsychotic medications and several hormones known to influence appetite regulation and carbohydrate metabolism. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:98 / 104
页数:7
相关论文
共 50 条
  • [1] Glucose metabolism in patients with schizophrenia treated with antipsychotic agents
    Fukui, Naoki
    Suzuki, Yutaro
    Sawamura, Kazushi
    Sugai, Takuro
    Watanabe, Junzo
    Ono, Shin
    Murata, Shigeo
    Suzuki, Yuji
    Someya, Toshiyuki
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (05) : A10 - A10
  • [2] Relationship of tardive dyskinesia and EPS to glucose and lipid metabolism in patients treated conventional and atypical antipsychotic medications
    Smith, RC
    Bark, N
    Vaidhyanathaswamy, S
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S254 - S254
  • [3] Abnormalities of glucose metabolism associated with atypical antipsychotic drugs
    Newcomer, JW
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 : 36 - 46
  • [4] Severity in schizophrenia patients receiving atypical antipsychotic medications
    Fatmi, Syed Meraj Alam
    Koul, Rakesh
    Prakash, Suruchi
    Ayub, Sheenam
    [J]. BIOINFORMATION, 2022, 18 (12) : 1154 - 1158
  • [5] Glucose and lipid metabolism in patients treated with atypical and conventional antipsychotic medication
    Lindenmayer, J
    Smith, RC
    Bark, N
    Khandat, A
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 361 - 361
  • [6] Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications
    Light, GA
    Geyer, MA
    Clementz, BA
    Cadenhead, KS
    Braff, DL
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (05): : 767 - 771
  • [7] Atypical antipsychotic medications and the treatment of schizophrenia
    Lewis, DA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (02): : 177 - 179
  • [8] Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents - A frequently sampled intravenous glucose tolerance test and minimal model analysis
    Henderson, DC
    Caglicro, E
    Copeland, PM
    Borba, CP
    Evins, E
    Hayden, D
    Weber, MT
    Anderson, J
    Allison, DB
    Daley, TB
    Schoenfeld, D
    Goff, DC
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (01) : 19 - 28
  • [9] Atypical antipsychotic medications and memory enhancement in schizophrenia
    Sepehry, AA
    Honer, WG
    Thornton, AE
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 158 - 158
  • [10] The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia
    Chen, Lei
    McCombs, Jeffrey S.
    Park, Jinhee
    [J]. VALUE IN HEALTH, 2008, 11 (01) : 34 - 43